Prognostic value of cachexia index in HR +/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

BMC Cancer · 2026 · PMC13255495 · PMID 42045838

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

showed a trendp = 0.059so close (0.05 < p ≤ 0.1)

Low SMD showed a trend toward reduced OS (HR 0.49, 95% CI 0.23–1.03, p = 0.059), whereas low L3 SMI was significantly associated with shorter OS (HR 0.37, 95% CI 0.16–0.87, p = 0.023).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.